GFS
CVS icon

GYL Financial Synergies’s CVS Health CVS Stock Holding History

GYL Financial Synergies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,561
Closed -$204K – 369
2024
Q1 		$204K Sell
2,561
-476
-16% -$36.4K 0.02% 357
2023
Q4 		$240K Sell
3,037
-657
-18% -$46.8K 0.02% 319
2023
Q3 		$258K Sell
3,694
-81
-2% -$5.74K 0.03% 289
2023
Q2 		$261K Sell
3,775
-840
-18% -$59.8K 0.02% 296
2023
Q1 		$343K Buy
4,615
+344
+8% +$28.8K 0.04% 226
2022
Q4 		$398K Buy
4,271
+415
+11% +$40K 0.09% 148
2022
Q3 		$368K Buy
3,856
+1
+0% +$99 0.1% 131
2022
Q2 		$357K Buy
3,855
+716
+23% +$69.9K 0.1% 133
2022
Q1 		$318K Sell
3,139
-7,791
-71% -$818K 0.08% 152
2021
Q4 		$1.13M Sell
10,930
-266
-2% -$24.6K 0.3% 54
2021
Q3 		$950K Sell
11,196
-348
-3% -$29.1K 0.49% 43
2021
Q2 		$963K Buy
11,544
+110
+1% +$9.01K 0.5% 45
2021
Q1 		$860K Sell
11,434
-146
-1% -$10.6K 0.47% 47
2020
Q4 		$791K Sell
11,580
-204
-2% -$13.3K 0.46% 52
2020
Q3 		$688K Buy
11,784
+2,015
+21% +$125K 0.45% 53
2020
Q2 		$635K Buy
+9,769
New +$615K 0.46% 52
2020
Q1 		– Sell
-3,432
Closed -$255K – 153
2019
Q4 		$255K Sell
3,432
-1,068
-24% -$75K 0.11% 156
2019
Q3 		$284K Sell
4,500
-342
-7% -$20.3K 0.14% 129
2019
Q2 		$264K Sell
4,842
-98
-2% -$5.28K 0.14% 125
2019
Q1 		$266K Sell
4,940
-295
-6% -$18.2K 0.15% 118
2018
Q4 		$343K Buy
+5,235
New +$391K 0.25% 81

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

GYL Financial Synergies's CVS Position: Q2 2024 in Review

GYL Financial Synergies sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,561 shares — an estimated $204K sold.

GYL Financial Synergies first reported a position in CVS in Q4 2018 and held it in 21 quarters. The position peaked at $1.13M in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • GYL Financial Synergies reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • GYL Financial Synergies sold 2,561 CVS Health shares in Q2 2024, an estimated $204K.
  • GYL Financial Synergies first reported a position in CVS Health in Q4 2018 and held it in 21 quarters.
  • GYL Financial Synergies's CVS Health position peaked at $1.13M in Q4 2021.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on GYL Financial Synergies's 13F filing for Q2 2024, filed 23 Jul 2024.